GlassScriptPhysician profile
Andrew S Lim
NPI 1831172162
$2,022.69
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $582 · 2020: $173 · 2021: $921 · 2022: $208 · 2024: $139.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $139.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $138.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $718.67 | 2019-2021 | |
| Glaxosmithkline, LLC. | $227.15 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $205.71 | 2019 | |
| Dexcom, INC. | $138.81 | 2024 | Dexcom G7 Gss (161) |
| Novartis Pharmaceuticals Corporation | $115.18 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $101.96 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $100.59 | 2021 | |
| Allergan, INC. | $91.13 | 2020 | |
| Abbvie INC. | $88.90 | 2022 | |
| Redhill Biopharma INC. | $84.04 | 2021 | |
| Lilly USA, LLC | $81.88 | 2020 | |
| Pfizer INC. | $34.95 | 2019 | |
| Incyte Corporation | $33.72 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Lim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.